Source: Annual Congress 2008 - Basic science in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Roth, M. Tamm (Basel, Switzerland). Omalizumab inhibits IgE-induced cytokine secretion by human airway smooth muscle cells. Eur Respir J 2008; 32: Suppl. 52, 3570

Member's Comments

No comment yet.

Related content which might interest you: IgE-induced pro-inflammatory extracellular matrix composition in airway smooth muscle cells is prevented by omalizumab Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Omalizumab inhibits IgE-induced extracellular matrix deposition by asthmatic airway smooth muscle cells Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011 Inhibition of IgE-induced airway smooth muscle cell constriction by the anti-IgE-antibody omalizumab Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008 Eotaxin/CCL11 inhibits proliferation of human airway smooth muscle cells Source: Eur Respir J 2005; 26: Suppl. 49, 127s Year: 2005 Effects of IL-5 and IL-13 on human airway smooth muscle migration, proliferation and cytokine synthesis Source: Eur Respir J 2005; 26: Suppl. 49, 128s Year: 2005 Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002 Glutathionylation of IκB-α inhibits NF-κB dependent chemokine secretion in airway smooth muscle cells Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1 Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Heme-oxygenase (HO)-1 inhibits TNF-α induced CXCL10 secretion by airway smooth muscle cells Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011 TLR3/TAK1 signalling regulates rhinovirus-induced interleukin-33 in bronchial smooth muscle cells Source: ERJ Open Res, 6 (4) 00147-2020; 10.1183/23120541.00147-2020 Year: 2020 Bosentan blocks TNFα-induced GM-CSF expression in human airway smooth muscle cells Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Attenuation of human bronchial smooth muscle cell proliferation by rapamycin in Th2 cytokine dominant status Source: Eur Respir J 2006; 28: Suppl. 50, 230s Year: 2006 Asthmatic and non-asthmatic airway smooth muscle production of the mast cell chemotaxin CXCL10 involves MAPK Source: Eur Respir J 2006; 28: Suppl. 50, 854s Year: 2006 Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle Source: Eur Respir J 2004; 24 : 559-567 Year: 2004 Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in COPD Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010 Beta2-agonists but not glucocorticoids inhibit proliferation of asthmatic airway smooth muscle cells Source: Eur Respir J 2004; 24: Suppl. 48, 251s Year: 2004 Transcriptional regulation of CXCL8 hypersecretion in asthmatic airway smooth muscle cells Source: Annual Congress 2009 - Airway cell biology Year: 2009 Cytokines IL-4 and GM-CSF up regulate CD23 expression in human airway smooth muscle cells Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Remicade suppresses cytokine-induced up-regulation of bradykinin receptor-mediated airway smooth muscle contractions Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions Year: 2005